HPV持续性感染与免疫调节机制

[1] Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development. Routes JM,Ryan S,Li H,et al. Journal of Virology . 2000

[2] Control of interferon signaling in human papillomavirus infection. Koromilas AE,Li S,Matlashewski G. Cytokine and Growth Factor Reviews . 2001

[3] Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. Maciag PC,Schlecht NF,Souza PSA,et al. The Journal of Infectious Diseases . 2002

[4] Microarray analysis identified interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. Chang YE,Laimins LA. Journal of Virology . 2000

[5] Influence of the mucosal epithelium microenvironment on langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Giannini SL,Hubert P,Doyen J,et al. International Journal of Cancer . 2002

[6] Neutralizing antibodies against oncogenic human papillomavirus as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia. Kawana K,Yasugi T,Kanda T,et al. Biochemical and Biophysical Research Communications . 2002

[7] Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Georgopoulos NT,Proffitt JL,Blair GE. Oncegene . 2000

[8] The antigen-presenting environment in normal and human papillomavirus(HPV)-related premalignant cervical epithelium. Mota F,Rayment N,Chong S,et al. Clinical and Experimental Immunology . 1999

[9] Down modulation of IL-18 expression by human papillomavirus type 16 E6. Cho YS,Kang JW,Cho M,et al. FEBS Letters . 2001

[10] Use of fluorogenic histocompatibility leukocyte antigen-A* 0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens. Youde SJ,Dunbar PR,Evans EM,et al. Cancer Research . 2000

[1] Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development. Routes JM,Ryan S,Li H,et al. Journal of Virology . 2000

[2] Control of interferon signaling in human papillomavirus infection. Koromilas AE,Li S,Matlashewski G. Cytokine and Growth Factor Reviews . 2001

[3] Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. Maciag PC,Schlecht NF,Souza PSA,et al. The Journal of Infectious Diseases . 2002

[4] Microarray analysis identified interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. Chang YE,Laimins LA. Journal of Virology . 2000

[5] Influence of the mucosal epithelium microenvironment on langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Giannini SL,Hubert P,Doyen J,et al. International Journal of Cancer . 2002

[6] Neutralizing antibodies against oncogenic human papillomavirus as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia. Kawana K,Yasugi T,Kanda T,et al. Biochemical and Biophysical Research Communications . 2002

[7] Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Georgopoulos NT,Proffitt JL,Blair GE. Oncegene . 2000

[8] The antigen-presenting environment in normal and human papillomavirus(HPV)-related premalignant cervical epithelium. Mota F,Rayment N,Chong S,et al. Clinical and Experimental Immunology . 1999

[9] Down modulation of IL-18 expression by human papillomavirus type 16 E6. Cho YS,Kang JW,Cho M,et al. FEBS Letters . 2001

[10] Use of fluorogenic histocompatibility leukocyte antigen-A* 0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens. Youde SJ,Dunbar PR,Evans EM,et al. Cancer Research . 2000